A PTER inhibitor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

PTERi

Item No. 45644

Product Insert (PDF)
Technical Information
Formal Name
3-[2-[2-(1,3-dioxo-1H-benz[de]isoquinolin-2(3H)-yl)ethoxy]ethoxy]-N-hydroxy-propanamide
CAS Number
3114432-21-9
Synonyms
  • Phosphotriesterase-related Protein Inhibitor
Molecular Formula
C19H20N2O6
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥ 10 mg/ml
SMILES
ONC(CCOCCOCCN(C(C1=CC=CC2=CC=CC3=C12)=O)C3=O)=O
InChi Code
InChI=1S/C19H20N2O6/c22-16(20-25)7-9-26-11-12-27-10-8-21-18(23)14-5-1-3-13-4-2-6-15(17(13)14)19(21)24/h1-6,25H,7-12H2,(H,20,22)
InChi Key
ZVQXBSZUHNRXLS-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    PTERi is an inhibitor of phosphotriesterase-related protein (PTER; IC50 = 830 nM for the human enzyme), an aminohydrolase involved in the metabolism of the anorexigenic metabolite N-acetyl taurine (Item No. 35169).1 It is selective for PTER over a panel of 13 histone deacetylases (HDACs) and sirtuins (SIRTs) at 100 µM but does inhibit HDAC8 and HDAC10 by >80% at 100 µM. Acute administration of PTERi (100 mg/kg) increases plasma N-acetyl taurine levels in lean and diet-induced obese (DIO) mice and chronic administration over four weeks decreases food intake and body weight in DIO mice. It also enhances loss of body weight and reductions in food intake induced by semaglutide (Item Nos. 40231 | 29969 | 40170) in DIO mice.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Fu, S., Wang, L., Li, V.L., et al. A small molecule PTER-selective inhibitor reduces food intake and body weight. Cell Chem. Biol. 33(3), 353-363 (2026).